EUCTR2005-002216-25-DK进行中（未招募）不适用
A multicentre, randomised, open label, comparative Phase 4 trial to assess changes in clinical management after DaTSCAN™ imaging of subjects with clinically uncertain parkinsonism in a general neurologist setting
GE Healthcare Ltd and its affliates0 个研究点目标入组 250 人开始时间: 2006年10月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Subjects with clinically uncertain Parkinsonian Syndromes (PS) or monosymptomatic, atypical or incomplete presentation of tremor, rigidity, bradykinesia or postural instability.
- •Onset of clinical manifestations within the last 5 years.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Differential diagnosis between Parkinson’s Disease (PD) and Progressive Supranuclear Palsy (PSP) or between PD and Multiple System Atrophy (MSA).
- •Subjects with an established/certain movement disorder clinical diagnosis.
- •Presence of known causes of tremor (eg, hyperthyroidism).
- •Subjects with a significant cognitive impairment as confirmed by a Mini-Mental State Examination score <24.
研究者
相似试验
进行中（未招募）
不适用
A multicentre, randomised, open label, comparative Phase 4 trial to assess changes in dementia diagnostic category and diagnostic confidence after DaTSCAN imaging in subjects with an uncertain diagnosis of dementia with Lewy bodies (possible DLB) - NDEUCTR2010-021474-11-ITGE Healthcare Srl174
进行中（未招募）
不适用
A multicentre, randomised, open label, comparative Phase 4 trial to assess changes in clinical management after DaTSCAN imaging of subjects with clinically uncertain parkinsonism in a general neurologist setting - NDclinically uncertain parkinsonismMedDRA version: 6.1Level: PTClassification code 10034010EUCTR2005-002216-25-ITGE Healthcare Ltd e le sue filiali250
尚未招募
不适用
Study of the efficacy and safety of Tiotropium bromide,in patients with COPD.CTRI/2017/10/010024Rus Biopharm LLC
暂停
不适用
To evaluate efficacy and safety of Respiforb in patients with partly controlled asthmaCTRI/2018/09/015862PSK Pharma LLC
终止
4 期
Oestrogen cream or a simple lubricant to treat vaginal dryness in women on Arimidex treatment for breast cancerAtrophic vaginitisCancer - BreastRenal and Urogenital - Other renal and urogenital disordersBreast cancerACTRN12609000154202School of Women's and Infants' Health84